352 related articles for article (PubMed ID: 19178537)
1. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.
Bochner BS
Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement.
Yokoi H; Choi OH; Hubbard W; Lee HS; Canning BJ; Lee HH; Ryu SD; von Gunten S; Bickel CA; Hudson SA; Macglashan DW; Bochner BS
J Allergy Clin Immunol; 2008 Feb; 121(2):499-505.e1. PubMed ID: 18036650
[TBL] [Abstract][Full Text] [Related]
3. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.
Kiwamoto T; Kawasaki N; Paulson JC; Bochner BS
Pharmacol Ther; 2012 Sep; 135(3):327-36. PubMed ID: 22749793
[TBL] [Abstract][Full Text] [Related]
4. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand.
Tateno H; Crocker PR; Paulson JC
Glycobiology; 2005 Nov; 15(11):1125-35. PubMed ID: 15972893
[TBL] [Abstract][Full Text] [Related]
5. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
[TBL] [Abstract][Full Text] [Related]
6. Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death
Carroll DJ; Cao Y; Bochner BS; O'Sullivan JA
Front Immunol; 2021; 12():737988. PubMed ID: 34721399
[TBL] [Abstract][Full Text] [Related]
7. Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases.
O'Sullivan JA; Youngblood BA; Schleimer RP; Bochner BS
Semin Immunol; 2023 Sep; 69():101799. PubMed ID: 37413923
[TBL] [Abstract][Full Text] [Related]
8. Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfalls.
Knuplez E; Krier-Burris R; Cao Y; Marsche G; O'Sullivan J; Bochner BS
J Leukoc Biol; 2020 Jul; 108(1):43-58. PubMed ID: 32134149
[TBL] [Abstract][Full Text] [Related]
9. Sialylated keratan sulfate proteoglycans are Siglec-8 ligands in human airways.
Gonzalez-Gil A; Porell RN; Fernandes SM; Wei Y; Yu H; Carroll DJ; McBride R; Paulson JC; Tiemeyer M; Aoki K; Bochner BS; Schnaar RL
Glycobiology; 2018 Oct; 28(10):786-801. PubMed ID: 29924315
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6'-sulfated sialyl Lewis x.
Hudson SA; Bovin NV; Schnaar RL; Crocker PR; Bochner BS
J Pharmacol Exp Ther; 2009 Aug; 330(2):608-12. PubMed ID: 19458105
[TBL] [Abstract][Full Text] [Related]
11. Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating β
Carroll DJ; O'Sullivan JA; Nix DB; Cao Y; Tiemeyer M; Bochner BS
J Allergy Clin Immunol; 2018 Jun; 141(6):2196-2207. PubMed ID: 28888781
[TBL] [Abstract][Full Text] [Related]
12. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
[TBL] [Abstract][Full Text] [Related]
13. mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.
Yu Z; Maoui M; Wu L; Banville D; Shen S
Biochem J; 2001 Feb; 353(Pt 3):483-92. PubMed ID: 11171044
[TBL] [Abstract][Full Text] [Related]
14. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils.
Zhang M; Angata T; Cho JY; Miller M; Broide DH; Varki A
Blood; 2007 May; 109(10):4280-7. PubMed ID: 17272508
[TBL] [Abstract][Full Text] [Related]
15. Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils.
O'Sullivan JA; Wei Y; Carroll DJ; Moreno-Vinasco L; Cao Y; Zhang F; Lee JJ; Zhu Z; Bochner BS
J Leukoc Biol; 2018 Jul; 104(1):11-19. PubMed ID: 29601103
[TBL] [Abstract][Full Text] [Related]
16. Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily.
Floyd H; Ni J; Cornish AL; Zeng Z; Liu D; Carter KC; Steel J; Crocker PR
J Biol Chem; 2000 Jan; 275(2):861-6. PubMed ID: 10625619
[TBL] [Abstract][Full Text] [Related]
17. A Potent Mimetic of the Siglec-8 Ligand 6'-Sulfo-Sialyl Lewis
Kroezen BS; Conti G; Girardi B; Cramer J; Jiang X; Rabbani S; Müller J; Kokot M; Luisoni E; Ricklin D; Schwardt O; Ernst B
ChemMedChem; 2020 Sep; 15(18):1706-1719. PubMed ID: 32744401
[TBL] [Abstract][Full Text] [Related]
18. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M
Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002
[TBL] [Abstract][Full Text] [Related]
19. Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils.
Zimmermann N; McBride ML; Yamada Y; Hudson SA; Jones C; Cromie KD; Crocker PR; Rothenberg ME; Bochner BS
Allergy; 2008 Sep; 63(9):1156-63. PubMed ID: 18699932
[TBL] [Abstract][Full Text] [Related]
20. Discovery, Function, and Therapeutic Targeting of Siglec-8.
Youngblood BA; Leung J; Falahati R; Williams J; Schanin J; Brock EC; Singh B; Chang AT; O'Sullivan JA; Schleimer RP; Tomasevic N; Bebbington CR; Bochner BS
Cells; 2020 Dec; 10(1):. PubMed ID: 33374255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
